A systematic review and meta-analysis of clinical trials on the effects of glutamine supplementation on gut permeability in adults
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
The gastrointestinal tract's epithelial barrier plays a crucial role in maintaining health. This study aims to investigate the impact of glutamine supplementation on intestinal permeability, considering its importance for immune function and nutrient absorption. The study adhered to the PRISMA protocol for systematic reviews and meta-analyses. A systematic search was performed in four databases (PubMed, Scopus, Web of Science, and Google Scholar) until April 2023 to identify clinical trials on glutamine supplementation and gastrointestinal permeability. Eligibility criteria included randomized placebo-controlled trials measuring gut permeability post-glutamine supplementation. Studies were included regardless of language or publication date. Data extraction involved study characteristics, intervention details, and outcomes. Quality assessment was performed using the Cochrane tool, and statistical analysis utilized mean differences and standard deviations with a random effects model. Subgroup analysis was conducted to explore heterogeneity. The systematic review and meta-analysis included 10 studies from 1998 to 2014 with 352 participants. A total of 216 patients were enrolled in the intervention group, and 212 in the control group. The mean participant age was 46.52 years. The participants had different types of diseases in terms of their health status. Overall, glutamine supplementation did not significantly affect intestinal permeability (WMD: -0.00, 95% CI -0.04, 0.03). Subgroup analysis showed a significant reduction in intestinal permeability with doses over 30g/day (WMD: -0.01, 95% CI -0.10, -0.08). The glutamine supplements were administered orally in all included studies. The meta-analysis demonstrated a significant reduction in intestinal permeability with glutamine supplementation exceeding 30 mg/day for durations of less than 2 weeks. Further investigations with varying dosages and patient populations are warranted to enhance understanding and recommendations regarding glutamine supplementation's effects on gut permeability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Conversely, zinc deficiency disrupts glucose metabolism through β-cell dysfunction, oxidative stress, and inflammation [182].”
From Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review (2025) · cites this paper as [182]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042 · cited 1×
“We examined risk of bias for all included studies using the Cochrane quality assessment tool designed for clinical trials (Moher et al., 2009).”
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Wang, G., Ma, R., Qiao, G., Wada, K., Aizawa, Y., & Satoh, T. (2015) · Integrative Medicine International · doi:10.1159/000368408 · Cited by 18,657
Estimating the mean and variance from the median, range, and the size of a sample
Hozo, S. P., Djulbegovic, B., & Hozo, I. (2005) · BMC Medical Research Methodology · doi:10.1186/1471-2288-5-13 · Cited by 9,062
Intestinal barrier function in health and gastrointestinal disease
Camilleri, M., Madsen, K., Spiller, R., Van Meerveld, B. G., & Verne, G. N. (2012) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2012.01921.x · Cited by 908 · cited 1×
“Several factors can affect intestinal barrier integrity, including stress, microbial invasion, and immune responses to infections (Camilleri et al. 2012; Arrieta et al. 2006).”
BackgroundUptake and Metabolism of Plasma Glutamine by the Small Intestine
Windmueller, H. G., & Spaeth, A. E. (1974) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)42329-6 · Cited by 790
Alterations in intestinal permeability
Arrieta, M. C., Bistritz, L., & Meddings, J. B. (2006) · Gut · doi:10.1136/gut.2005.085373 · Cited by 634 · cited 1×
“Several factors can affect intestinal barrier integrity, including stress, microbial invasion, and immune responses to infections (Camilleri et al. 2012; Arrieta et al. 2006).”
BackgroundGlutamine and intestinal barrier function
Wang, B., Wu, G., Zhou, Z., Dai, Z., Sun, Y., Ji, Y., Li, W., Wang, W., Liu, C., Han, F., et al. (2015) · Amino Acids · doi:10.1007/s00726-014-1773-4 · Cited by 266 · cited 2×
“The gastrointestinal (GI) tract provides a large surface area for digesting and absorbing nutrients and excreting waste products from the body (Wang et al. 2015).”
BackgroundProtection and Restitution of Gut Barrier by Probiotics: Nutritional and Clinical Implications
Krishna Rao, R., & Samak, G. (2013) · Current Nutrition & Food Science · doi:10.2174/1573401311309020004 · Cited by 266
Zhou, Y., Jiang, Z., Sun, Y., Wang, X., Ma, E., & Wilmore, D. (2003) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607103027004241 · Cited by 206 · cited 3×
“In some included studies, placebo was used for control group (Conejero et al. 2002; Hond et al. 1999; Leite et al. 2013; Noyer et al 1998; Zhou et al. 2003), whereas others used active control group (Benjamin et al. 2012), best supportive care (Choi et al. 2007), isonitrogenous control solu-tion…”
BackgroundMethodShing, C. M., Peake, J. M., Lim, C. L., Briskey, D., Walsh, N. P., Fortes, M. B., Ahuja, K. D. K., & Vitetta, L. (2014) · European Journal of Applied Physiology · doi:10.1007/s00421-013-2748-y · Cited by 204
Marchbank, T., Davison, G., Oakes, J. R., Ghatei, M. A., Patterson, M., Moyer, M. P., & Playford, R. J. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00281.2010 · Cited by 163 · cited 1×
“(Zuhl et al. 2014; Marchbank et al. 2011; Shinget al. 2014; Milajerdiet al. 2021).”
Zuhl, M., Lanphere, K. R., Kravitz, L. R., Mermier, C. M., Schneider, S. M., Dokładny, K., & Moseley, P. L. (2013) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00646.2013 · Cited by 140 · cited 4×
“Glutamine is a key amino acid in the plasma, serving as a primary fuel for enterocytes and immune cells such as leukocytes and T lymphocytes (Zuhl et al. 2014).”
BackgroundInfluentialMilajerdi, A., Ebrahimi‐Daryani, N., Dieleman, L. A., Larijani, B. A., & Esmaillzadeh, A. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa145 · Cited by 132
Self-citationHond, E. D., Hiele, M. I., Peeters, M., Ghoos, Y. F., & Rutgeerts, P. J. (1999) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/014860719902300107 · Cited by 130 · cited 5×
“In some included studies, placebo was used for control group (Conejero et al. 2002; Hond et al. 1999; Leite et al. 2013; Noyer et al 1998; Zhou et al. 2003), whereas others used active control group (Benjamin et al. 2012), best supportive care (Choi et al. 2007), isonitrogenous control solu-tion…”
BackgroundMethodResultInfluentialConejero, R., Bonet, A., Grau, T., Esteban, A., Mesejo, A., Montejo, J. C., López, J., & Acosta, J. A. (2002) · Nutrition · doi:10.1016/s0899-9007(02)00847-x · Cited by 129 · cited 4×
“Most studies used “Lactulose/Mannitol Ratio” (Conejero et al. 2002; Leite et al. 2013; Noyer et al. 1998; Zhou et al. 2003; Benjamin et al. 2012; Hulsewé et al. 2004; Singh et al. 2014; Velasco et al. 2001; Quan et al. 2004) to assess intestinal permeability, while 2 studies used “51 Cr-E1DT” (Hond et al. 1999; Choi e…”
MethodInfluentialDokładny, K., Lobb, R., Wharton, W., Ma, T. Y., & Moseley, P. L. (2010) · Cell Stress and Chaperones · doi:10.1007/s12192-009-0129-6 · Cited by 117 · cited 1×
“In addition, some studies have indicated that pre-exercise glutamine supplementation is associated with decreased serum levels of pro-inflammatory cytokines (Paimela et al. 2011; Dokladny et al. 2010).”
BackgroundBenjamin, J., Makharia, G. K., Ahuja, V., Rajan, A., Kalaivani, M., Gupta, S. D., & Joshi, Y. K. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1947-9 · Cited by 92 · cited 4×
“Some studies enrolled participants with Crohn's disease (Benjamin et al. 2012; Den Hond et al. 1999), while others included HIV-positive adults (Leite et al. 2013; Noyer et al. 1998).”
BackgroundMethodInfluentialGlutamine and the regulation of intestinal permeability: from bench to bedside
Achamrah, N., Déchelotte, P., & Coëffier, M. (2016) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000339 · Cited by 86
Arike, L., Seiman, A., van der Post, S., Rodríguez-Piñeiro, A. M., Ermund, A., Schütte, A., Bäckhed, F., Johansson, M., & Hansson, G. C. (2020) · Cell Reports · doi:10.1016/j.celrep.2019.12.068 · Cited by 85 · cited 2×
“The para-cellular space between IECs is responsible for intestinal permeability (Arike et al. 2020).”
BackgroundChoi, K., Lee, S.-S., Oh, S., Lim, S., Lim, S.-Y., Jeon, W., Oh, T. Y., & Kim, J. W. (2007) · Clinical Nutrition · doi:10.1016/j.clnu.2006.07.003 · Cited by 84 · cited 4×
“…Ratio” (Conejero et al. 2002; Leite et al. 2013; Noyer et al. 1998; Zhou et al. 2003; Benjamin et al. 2012; Hulsewé et al. 2004; Singh et al. 2014; Velasco et al. 2001; Quan et al. 2004) to assess intestinal permeability, while 2 studies used “51 Cr-E1DT” (Hond et al. 1999; Choi et al. 2007).”
BackgroundMethodInfluentialUeno, P. M., Oriá, R. B., Maier, E. A., Guedes, M. M., de Azevedo, O. G. R., Wu, D. X.-Y., Willson, T. A., Hogan, S. P., Lima, A. Â. M., Guerrant, R. L., et al. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00531.2010 · Cited by 84 · cited 1×
“Depletion of glutamine during infection or illness results in atrophy and hyper-permeability of intestinal epithelial cells (Ueno et al. 2011; Ropeleski et al. 2005).”
BackgroundYaqoob, P., & Calder, P. C. (1998) · Cytokine · doi:10.1006/cyto.1998.0358 · Cited by 83 · cited 1×
“Research has shown that a deficiency in glutamine can impair the ability of leukocytes to produce cytokines in response to bacterial infections (Yaqoob et al. 1998).”
BackgroundBeutheu, S., Ouelaa, W., Guérin, C., Belmonte, L., Aziz, M., Tennoune, N., Bôle‐Feysot, C., Galas, L., Déchelotte, P., & Coëffier, M. (2013) · Clinical Nutrition · doi:10.1016/j.clnu.2013.09.003 · Cited by 72 · cited 1×
“Conversely, Beutheu et al. found that glutamine supplementation significantly improved impaired intestinal permeability when used alone, not in combination with other amino acids (Beutheu et al. 2014).”
BackgroundPugh, J. N., Sage, S., Hutson, M., Doran, D. A., Fleming, S. C., Highton, J., Morton, J. P., & Close, G. L. (2017) · European Journal of Applied Physiology · doi:10.1007/s00421-017-3744-4 · Cited by 64 · cited 4×
“For instance, a 2017 study demonstrated that even low doses of oral glutamine (0.25 g/kg) reduced intestinal permeability, with higher doses showing more pronounced effects (Pugh et al. 2017).”
BackgroundInfluentialRopeleski, M. J., Riehm, J., Baer, K. A., Musch, M. W., & Chang, E. B. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.05.017 · Cited by 55 · cited 1×
“Depletion of glutamine during infection or illness results in atrophy and hyper-permeability of intestinal epithelial cells (Ueno et al. 2011; Ropeleski et al. 2005).”
BackgroundNoyer, C. M., Simon, D. M., Borczuk, A., Brandt, L. J., Lee, M. J., & Nehra, V. (1998) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1998.00290.x · Cited by 53 · cited 4×
“Some studies enrolled participants with Crohn's disease (Benjamin et al. 2012; Den Hond et al. 1999), while others included HIV-positive adults (Leite et al. 2013; Noyer et al. 1998).”
BackgroundMethodInfluentialMadni, A., Rehman, S., Sultan, H., Khan, M. M., Ahmad, F., Raza, M. R., Rai, N., & Parveen, F. (2020) · AAPS PharmSciTech · doi:10.1208/s12249-020-01873-z · Cited by 53 · cited 1×
“This tract is lined by a single layer of epithelial cells, forming a crucial protective barrier against microbial invasion (Madni et al. 2020; Hallajzadeh et al. 2019; Shahinfar et al. 2021).”
BackgroundPaimela, T., Hyttinen, J. M. T., Viiri, J., Ryhänen, T., Karjalainen, R., Salminen, A., & Kaarniranta, K. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.05.027 · Cited by 52 · cited 1×
“In addition, some studies have indicated that pre-exercise glutamine supplementation is associated with decreased serum levels of pro-inflammatory cytokines (Paimela et al. 2011; Dokladny et al. 2010).”
BackgroundGlutamine: An Essential Amino Acid for the Gut
van der Hulst, R. R. (1996) · Nutrition · doi:10.1016/s0899-9007(97)85206-9 · Cited by 52 · cited 1×
“Glutamine as a non-essential amino acid has a vital role in dividing of epithelial cells in the gastrointestinal tract (Van der Hulst et al. 1996).”
BackgroundKhademi, Z., Milajerdi, A., Larijani, B. A., & Esmaillzadeh, A. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.707795 · Cited by 50 · cited 1×
“For instance, certain dietary components, such as high-fat or high-sugar diets, have been linked to increased intestinal permeability and inflammation (Khademi et al. 2021; Milajerdi et al. 2020).”
BackgroundSelf-citationSevero, J. S., Barros, V. J. D. S., da Silva, A. C. A., Parente, J. M. L., Lima, M. M., Lima, A. Â. M., dos Santos, A. A., Neto, E. M. D. M., & da Silva, M. T. B. (2021) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2020.12.023 · Cited by 46 · cited 1×
“…trials investigating “the effect of glutamine supplementation on IBD patients”, no significant result was reached for disease course, anthropometric measurements, and intestinal permeability and morphology in patients with IBD, regardless of the route of administration (Severo et al. 2021).”
BackgroundHallajzadeh, J., Milajerdi, A., Kolahdooz, F., Amirani, E., Mirzaei, H., & Asemi, Z. (2019) · Phytotherapy Research · doi:10.1002/ptr.6477 · Cited by 45 · cited 1×
“This tract is lined by a single layer of epithelial cells, forming a crucial protective barrier against microbial invasion (Madni et al. 2020; Hallajzadeh et al. 2019; Shahinfar et al. 2021).”
BackgroundSelf-citationQuan, Z.-F. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i13.1992 · Cited by 42
Hulsewé, K. W. E., van Acker, B. A. C., Hameeteman, W. M., van der Hulst, R. R. W. J., Vainas, T., Arends, J., van Kreel, B. K., MEYENFELDT, M. F. V., & Soeters, P. B. (2004) · Clinical Nutrition · doi:10.1016/j.clnu.2004.04.002 · Cited by 37 · cited 4×
“…2003), whereas others used active control group (Benjamin et al. 2012), best supportive care (Choi et al. 2007), isonitrogenous control solu-tion (Hulsewé et al. 2004), 20 g/day whey protein (Singh et al. 2014), 0.15 g/kg/day glutamine (Velasco et al. 2001), and no glutamine diet (Quan et al.…”
BackgroundMethodInfluentialVelasco, N., Hernández, G., Wainstein, C., Castillo, L., Maíz, A., López, F., Guzmán, S., Bugedo, G., Acosta, A., & Bruhn, A. (2001) · Nutrition (Burbank, Los Angeles County, Calif.) · doi:10.1016/s0899-9007(01)00613-x · Cited by 29 · cited 4×
“Two studies justified the baseline value (Hond et al. 1999; Velasco et al. 2001), while the others did not justify their findings for the possible confounders (Cone-jero et al. 2002; Leite et al. 2013; Noyer et al. 1998; Zhou et al. 2003; Benjamin et al. 2012; Choi et al. 2007; Hulsewé et al. 2004;…”
MethodResultInfluentialSingh, N., Mishra, S. K., Sachdev, V., Sharma, H., Upadhyay, A. D., Arora, I., & Saraya, A. (2014) · Pancreas · doi:10.1097/mpa.0000000000000124 · Cited by 27 · cited 4×
“…et al. 1999; Velasco et al. 2001), while the others did not justify their findings for the possible confounders (Cone-jero et al. 2002; Leite et al. 2013; Noyer et al. 1998; Zhou et al. 2003; Benjamin et al. 2012; Choi et al. 2007; Hulsewé et al. 2004; Singh et al. 2014; Quan et al. 2004) Table 2.”
BackgroundMethodInfluentialShariatpanahi, Z. V., Eslamian, G., Ardehali, S. H., & Baghestani, A. R. (2019) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-23218 · Cited by 24 · cited 1×
“In another study, early enteral glutamine supplementation led to a declined intestinal permeability in critically ill patients (Shariatpanahi et al. 2019).”
BackgroundIMPROVEMENT OF INTESTINAL PERMEABILITY WITH ALANYL-GLUTAMINE IN HIV PATIENTS:
Leite, R. D., Lima, N. L., Leite, C. A. C., Farhat, C. K., Guerrant, R. L., & Lima, A. Â. M. (2013) · Arquivos de Gastroenterologia · doi:10.1590/s0004-28032013000100011 · Cited by 20 · cited 4×
“Some studies enrolled participants with Crohn's disease (Benjamin et al. 2012; Den Hond et al. 1999), while others included HIV-positive adults (Leite et al. 2013; Noyer et al. 1998).”
BackgroundMethodInfluentialMilajerdi, A., Abbasi, F., & Esmaillzadeh, A. (2021) · Nutrition Reviews · doi:10.1093/nutrit/nuab028 · Cited by 20 · cited 1×
“Moreover, elevated intestinal permeability can impair epithelial cell function and reduce nutrient absorption efficiency (Zuhl et al. 2014; Milajerdi et al. 2022).”
BackgroundSelf-citationShahinfar, H., Payandeh, N., Elhamkia, M., Abbasi, F., Alaghi, A., Djafari, F., Eslahi, M., Gohari, N. S. F., Ghorbaninejad, P., Hasanzadeh, M., et al. (2021) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2021.102787 · Cited by 14 · cited 1×
“This tract is lined by a single layer of epithelial cells, forming a crucial protective barrier against microbial invasion (Madni et al. 2020; Hallajzadeh et al. 2019; Shahinfar et al. 2021).”
BackgroundSelf-citationMetaanalysis on obesity and risk of inflammatory bowel disease: Reanalysis is needed
Milajerdi, A., Larijani, B. A., & Esmaillzadeh, A. (2019) · Obesity Reviews · doi:10.1111/obr.12965 · Cited by 2 · cited 1×
“For instance, certain dietary components, such as high-fat or high-sugar diets, have been linked to increased intestinal permeability and inflammation (Khademi et al. 2021; Milajerdi et al. 2020).”
BackgroundSelf-citation
Research works printed but not linked: 1
- Quan Z-F, Yang C, Li N, Li J-S (2004) Effect of glutamine on change in early postoperative intestinal permeability and its relation to systemic inflammatory response. World J Gastroenterology: WJG 10(13):1992 · DOI · Paper page
Cited by
A Cascade of Microbiota-Leaky Gut-Inflammation- Is it a Key Player in Metabolic Disorders?
Mishra, S. P., Jain, S., Agadzi, B., & Yadav, H. (2025) · Current Obesity Reports · doi:10.1007/s13679-025-00624-0 · Cited by 69
Macronutrients as Regulators of Intestinal Epithelial Permeability: Where Do We Stand?
Martínez‐Augustin, O., Tena‐Garitaonaindia, M., Ceacero‐Heras, D., Jiménez‐Ortas, Á., Enguix-Huete, J. J., Álvarez‐Mercado, A. I., Ruiz‐Henares, G., Aranda, C. J., Gámez‐Belmonte, R., & de Medina, F. S. (2025) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.70178 · Cited by 19
Strategies to Maximize the Benefits of Evidence-Based Enteral Nutrition: A Narrative Review
Kano, K.-I., Yamamoto, R., Yoshida, M., Sato, T., Nishita, Y., Ito, J., Nagatomo, K., Ohbe, H., Takahashi, K., Kaku, M., et al. (2025) · Nutrients · doi:10.3390/nu17050845 · Cited by 16
“As some amino acids provided via EN, such as glutamine and arginine, offer additional immunomodulatory benefits, enteral glutamine serves as a primary energy source for small intestinal cells, supporting intestinal barrier function [49,50].”
Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review
Dias, D. D., Vasconcelos, A. R., Souza, A. C. R., Menezes, C. D., Silva, I. S. T. E., & Name, J. J. (2025) · Obesities · doi:10.3390/obesities5040088 · Cited by 8
“…of 10 randomized controlled trials ( n = 352) found that while glutamine overall did not significantly alter gut permeability, subgroup analyses revealed a reduction at doses >30 g/day for less than 2 weeks, supporting context-specific efficacy to strengthen the epithelial barrier [179].”
Bone Broth Benefits: How Its Nutrients Fortify Gut Barrier in Health and Disease
Matar, A., Abdelnaem, N., & Camilleri, M. (2025) · Digestive Diseases and Sciences · doi:10.1007/s10620-025-08997-x · Cited by 4
“However, in a subgroup analysis, GLN doses exceeding 30 g per day led to a significant reduction in gut permeability (WMD: − 0.01, 95% CI − 0.10 to − 0.08), particularly when the supplementation duration was under 2 weeks [43].”
Influential
Metadata
- Authors
- Abbasi, F., Haghighat Lari, M. M., Khosravi, G. R., Mansouri, E., Payandeh, N., & Milajerdi, A.
- Affiliations
- University of Tehran (IR)
- Kashan University of Medical Sciences (IR)
- Tehran University of Medical Sciences (IR)
- Corresponding author
- Milajerdi, Alireza
- Venue
- Amino Acids
- Published
- 2024-10-13
- Volume
- 56
- Issue
- 1
- Pages
- 60-60
- ISSN
- 0939-4451 (ISSN-L)
- 1438-2199
- PMC
- PMC11471693
- OpenAlex
- W4403366601
- Cited by
- 19
- References
- 44
- Citations by year
- 2026: 11 · 2025: 8
- FWCI
- 1.12
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0 (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0 (vor)
- Locations
- Amino Acids (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Clinical Nutrition and Gastroenterology
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Nutrition and Physiology
- Keywords
- glutamine supplementation, intestinal permeability, intestinal barrier, dietary supplementation, dose-response relationship, oral glutamine, adults
- MeSH terms
- Intestinal Barrier Function, Adult, Clinical Trials as Topic, Glutamine, Humans, Intestinal Mucosa, Permeability, Randomized Controlled Trials as Topic, Dietary Supplements, Gastrointestinal Tract
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.